Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 633.07 billion as of September 26, 2025. Its market cap has decreased by -28.21% in one year.

Market Cap

633.07B

Enterprise Value

633.28B

Revenue

320.25B

Ranking

n/a

PE Ratio

18.69

Stock Price

1,090.00

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 633.07B, an increase of 6,492.27%. That is a compound annual growth rate of 19.74%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	633.07B	-18.32%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	539.83B	101.66%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,807.02B
Divi's Laboratories	1,510.38B
Cipla	1,211.15B
Apollo Hospitals Enterprise	1,079.82B
Mankind Pharma	1,024.84B
Zydus Lifesciences	981.08B
Fortis Healthcare	704.19B
Alkem Laboratories	649.60B

Market Cap Rankings